Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab. (Record no. 23977882)

MARC details
000 -LEADER
fixed length control field 00910 a2200241 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516222058.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201407s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1318-2099
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.2478/raon-2013-0083
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Königsberg, Robert
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20140703
245 00 - TITLE STATEMENT
Title Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Radiology and oncology
Date of publication, distribution, etc. Jun 2014
300 ## - PHYSICAL DESCRIPTION
Extent 184-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Maierhofer, Julia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Steininger, Tanja
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kienzer, Gabriele
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dittrich, Christian
773 0# - HOST ITEM ENTRY
Title Radiology and oncology
Related parts vol. 48
-- no. 2
-- p. 184-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.2478/raon-2013-0083">https://doi.org/10.2478/raon-2013-0083</a>
Public note Available from publisher's website

No items available.